Delay to institution of therapy and indu
β
Timo MΓΆttΓΆnen; Pekka Hannonen; Markku Korpela; Martti NissilΓ€; Hannu Kautiainen;
π
Article
π
2002
π
John Wiley and Sons
π
English
β 59 KB
π 2 views
## Abstract ## Objective To study the impacts of 1) the delay from the onset of symptoms to the institution of diseaseβmodifying antirheumatic drug (DMARD) therapy, 2) two treatment strategies (treatment with a combination of DMARDs or with a single drug), and 3) the presence of HLAβDRB1 alleles (